The best clinical benefit from the quantitative analysis of these markers will be obtained when the individual variables are combined to generate the CIS point method for a reliable bacterial infection marker, DNAVS point for differentiating between DNA and RNA virus infections, CD64 score point for a marker of febrile infection and CRP/CD11b ratio for a marker of gram-positive sepsis. This evidence concerns the gene FCGR1A and bacterial infectious disease.